{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:51:57Z","timestamp":1791352317878,"version":"4.3.1"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2010,5,20]],"date-time":"2010-05-20T00:00:00Z","timestamp":1274313600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2010,5,20]],"date-time":"2010-05-20T00:00:00Z","timestamp":1274313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1111\/j.1365-2133.2010.09836.x","type":"journal-article","created":{"date-parts":[[2010,5,22]],"date-time":"2010-05-22T15:39:45Z","timestamp":1274542785000},"page":"1172-1179","source":"Crossref","is-referenced-by-count":82,"title":["Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010"],"prefix":"10.1093","volume":"162","author":[{"given":"M.J.D.","family":"Goodfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.H.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bowser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.G.","family":"Millard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.B.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Ormerod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,5,20]]},"reference":[{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB1|cit1","first-page":"43.1","volume-title":"Rook\u2019s Textbook of Dermatology","author":"Cunliffe","year":"2004"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0190-9622(88)80249-4","article-title":"Isotretinoin and teratogenicity","volume":"19","author":"Strauss","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0190-9622(83)80154-6","article-title":"Depression - a side effect of 13-cis-retinoic acid therapy","volume":"9","author":"Hazen","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/sder.2001.28209","article-title":"Safety issues in isotretinoin therapy","volume":"20","author":"Hanson","year":"2001","journal-title":"Semin Cutan Med Surg"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/bmj.316.7133.723f","article-title":"Acne drug is linked to severe depression","volume":"316","author":"Josefson","year":"1998","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB6|cit6","unstructured":"U.S. Food and Drug Administration iPLEDGE 2007 Update http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm094306.htm"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000246134","article-title":"Roaccutane treatment guidelines: results of an international survey","volume":"194","author":"Cunliffe","year":"1997","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2133.2007.08399.x","article-title":"Pitfalls of prescribing acne therapies including isotretinoin for pilots","volume":"158","author":"Taibjee","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1365-2133.1993.tb03336.x","article-title":"Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests","volume":"129","author":"Barth","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/095466301750163509","article-title":"Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests?","volume":"12","author":"Alcalay","year":"2001","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archderm.142.8.1016","article-title":"A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris","volume":"142","author":"Zane","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"582","DOI":"10.7326\/0003-4819-136-8-200204160-00007","article-title":"High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study","volume":"136","author":"Rodondi","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00005053-197207000-00008","article-title":"Pseudotumor cerebri, psychosis and hypervitaminosis A","volume":"155","author":"Restak","year":"1972","journal-title":"J Nerv Ment Dis"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/bmj.298.6678.964","article-title":"Depression induced by etretinate","volume":"298","author":"Henderson","year":"1989","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB15|cit15","first-page":"64","article-title":"Does isotretinoin cause depression and suicide?","volume":"37","author":"Bremner","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0190-9622(82)80054-6","article-title":"Short clinical reports","volume":"6","author":"Meyskens","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1126\/science.279.5352.863","article-title":"Impaired locomotion and dopamine signaling in retinoid receptor mutant mice","volume":"279","author":"Krezel","year":"1998","journal-title":"Science"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1176\/appi.ajp.162.5.983","article-title":"Functional brain imaging alterations in acne patients treated with isotretinoin","volume":"162","author":"Bremner","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/sj.npp.1300998","article-title":"Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice","volume":"31","author":"O\u2019Reilly","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/toxsci\/kfi262","article-title":"Chronic oral treatment with 13-cis-retinoic acid (isotretinoin) or all-trans-retinoic acid does not alter depression-like behaviors in rats","volume":"87","author":"Ferguson","year":"2005","journal-title":"Toxicol Sci"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1744-859X-8-2","article-title":"Isotretinoin and psychopathology: a review","volume":"8","author":"Kontaxakis","year":"2009","journal-title":"Ann Gen Psychiatry"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pnpbp.2007.07.001","article-title":"The neurobiology of retinoic acid in affective disorders","volume":"32","author":"Bremner","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1073\/pnas.0306336101","article-title":"13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice","volume":"101","author":"Crandall","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0190-9622(08)80509-9","article-title":"Acute depression from isotretinoin","volume":"25","author":"Gatti","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/070674379504000915","article-title":"Depression associated with isotretinoin therapy","volume":"40","author":"Byrne","year":"1995","journal-title":"Can J Psychiatry"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0190-9622(08)81018-3","article-title":"Acute depression from isotretinoin","volume":"22","author":"Scheinman","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.euroneuro.2005.11.006","article-title":"Increased use of mental health services related to isotretinoin treatment: a 5-year analysis","volume":"16","author":"Friedman","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/archderm.141.5.557","article-title":"Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study","volume":"141","author":"Chia","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/09546630410033817","article-title":"Depression is not common in isotretinoin-treated acne patients","volume":"15","author":"Rohrback","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/09546630410027472","article-title":"A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin","volume":"15","author":"Ferahbas","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB31|cit31","first-page":"227","article-title":"No association found between patients receiving isotretinoin for acne and the development of depression in a Canadian prospective cohort","volume":"14","author":"Cohen","year":"2007","journal-title":"Can J Clin Pharmacol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2466\/PR0.99.7.897-906","article-title":"Incidence of depression related to isotretinoin treatment in 100 acne vulgaris patients","volume":"99","author":"Kaymak","year":"2006","journal-title":"Psychol Rep"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.1440-0960.2002.00612.x","article-title":"Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy","volume":"43","author":"Ng","year":"2002","journal-title":"Australas J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-4632.2006.02660.x","article-title":"Isotretinoin and the controversy of psychiatric adverse effects","volume":"45","author":"Strahan","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00128071-200304070-00005","article-title":"Isotretinoin use and subsequent depression and suicide: presenting the evidence","volume":"4","author":"Hull","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.sder.2005.04.003","article-title":"Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review","volume":"24","author":"Marqueling","year":"2005","journal-title":"Semin Cutan Med Surg"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB37|cit37","unstructured":"Medicines and Healthcare Products Regulatory Agency Download Drug Analysis Prints (DAPs) http:\/\/www.mhra.gov.uk\/Onlineservices\/Medicines\/Druganalysisprints\/index.htm"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1067\/mjd.2001.117730","article-title":"An analysis of reports of depression and suicide in patients treated with isotretinoin","volume":"45","author":"Wysowski","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archderm.136.10.1231","article-title":"Isotretinoin use and risk of depression, psychotic symptoms, suicide and attempted suicide","volume":"136","author":"Jick","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2133.1999.02662.x","article-title":"The psychological and emotional impact of acne and the effect of treatment with isotretinoin","volume":"140","author":"Kellett","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0190-9622(87)70166-2","article-title":"Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin","volume":"17","author":"Rubinow","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4088\/JCP.v69n0403","article-title":"Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study","volume":"69","author":"Azoulay","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jad.2009.09.005","article-title":"Psychiatric reactions to isotretinoin in patients with bipolar disorder","volume":"122","author":"Schaffer","year":"2010","journal-title":"J Affect Disord"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00004850-200501000-00008","article-title":"Affective psychosis following Accutane (isotretinoin) treatment","volume":"20","author":"Barak","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"issue":"Suppl. 55","key":"10.1111\/j.1365-2133.2010.09836.x-BIB45|cit45","first-page":"16","article-title":"Adverse mood and behaviour change in young patients on systemic isotretinoin","volume":"141","author":"Millard","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1440-1614.2003.01111.x","article-title":"The association between depression and isotretinoin use in acne","volume":"37","author":"Ng","year":"2003","journal-title":"Aust NZ J Psychiatry"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00045391-200303000-00012","article-title":"Overview of existing research and information linking isotretinoin (Accutane), depression, psychosis, and suicide","volume":"10","author":"O\u2019Donnell","year":"2003","journal-title":"Am J Ther"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2230.2006.02183.x","article-title":"The British Association of Dermatologists isotretinoin questionnaire for patients: a useful clinical tool","volume":"31","author":"McMullen","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1067\/mjd.2001.118233","article-title":"Suicide, depression and isotretinoin: is there a causal link?","volume":"45","author":"Jacobs","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB50|cit50","volume-title":"Beck Depression Inventory Manual","author":"Beck","year":"1996"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000012364","article-title":"Development of a brief screening instrument: the HANDS","volume":"69","author":"Baer","year":"2000","journal-title":"Psychother Psychosom"},{"key":"10.1111\/j.1365-2133.2010.09836.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/bmj.325.7356.149","article-title":"Depression in medical patients","volume":"325","author":"Peveler","year":"2002","journal-title":"BMJ"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2010.09836.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2010.09836.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2010.09836.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:48:59Z","timestamp":1676382539000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/162\/6\/1172\/6642716"}},"subtitle":["Isotretinoin in acne"],"short-title":[],"issued":{"date-parts":[[2010,5,20]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09836.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5,20]]}}}